Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
R. Rosell (Badalona (Barcelona), Spain). Genetics and tailored treatment of lung cancer. Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Innovative local therapies in lung cancer Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy Year: 2018 Lung cancer investigations and treatment Source: Breathe 2011; 7: 313-314 Year: 2011 Targeted therapy for lung cancer Source: Eur Respir J 2015; 46: 1239-1241 Year: 2015 Screening for lung cancer Source: International Congress 2017 – Lung cancer for the pulmonologist Year: 2017 Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Lung cancer: does age affect treatment strategy? Source: Eur Respir Mon; 2009: 43:306–326 Year: 2009 Chemotherapy for small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006 The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 Surgical treatment of multiple primary lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 136s Year: 2006 Surgery for lung cancer Source: International Congress 2016 – ME7 Surgery for lung cancer Year: 2016 Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Population’s understanding and degree of participation of a screening lung cancer programme Source: International Congress 2015 – Quality management in lung cancer Year: 2015